Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice
Authors
Keywords
-
Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-14
DOI
10.1007/s12035-019-01849-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
- (2019) Amanda Cano et al. JOURNAL OF CONTROLLED RELEASE
- Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery
- (2018) Yaxi Li et al. Expert Opinion on Drug Discovery
- Endoplasmic reticulum chaperone GRP78 regulates macrophage function and insulin resistance in diet-induced obesity
- (2018) Jong Hun Kim et al. FASEB JOURNAL
- The critical role of epigallocatechin gallate in regulating mitochondrial metabolism
- (2018) Weimei Shi et al. Future Medicinal Chemistry
- Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future
- (2018) Jeffrey Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- Metabolic Dysfunction in Alzheimer’s Disease: From Basic Neurobiology to Clinical Approaches
- (2018) Julia R. Clarke et al. JOURNAL OF ALZHEIMERS DISEASE
- Microglia-Mediated Synapse Loss in Alzheimer's Disease
- (2018) Lawrence Rajendran et al. JOURNAL OF NEUROSCIENCE
- Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice
- (2018) Nupur M. Pathak et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer’s Disease
- (2018) Miren Ettcheto et al. MOLECULAR NEUROBIOLOGY
- Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases
- (2018) Monira Pervin et al. MOLECULES
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- Impaired peripheral glucose homeostasis and Alzheimer's disease
- (2018) Nadeeja Wijesekara et al. NEUROPHARMACOLOGY
- Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
- (2018) Marcelo N.N. Vieira et al. NEUROPHARMACOLOGY
- ER Proteostasis Control of Neuronal Physiology and Synaptic Function
- (2018) Gabriela Martínez et al. TRENDS IN NEUROSCIENCES
- ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
- (2018) Toshie Yoneyama et al. Journal of Cancer
- Green Tea Epigallocatechin-3-Gallate (EGCG) and Other Flavonoids Reduce Alzheimer's Amyloid-Induced Mitochondrial Dysfunction
- (2018) Natasa Dragicevic et al. JOURNAL OF ALZHEIMERS DISEASE
- The Pancreas-Brain Axis: Insight into Disrupted Mechanisms Associating Type 2 Diabetes and Alzheimer's Disease
- (2018) Gauri S. Desai et al. JOURNAL OF ALZHEIMERS DISEASE
- Decrease of ERK/MAPK Overactivation in Prefrontal Cortex Reverses Early Memory Deficit in a Mouse Model of Alzheimer's Disease
- (2018) Mariana Feld et al. JOURNAL OF ALZHEIMERS DISEASE
- Cocoa Extracts Reduce Oligomerization of Amyloid-β: Implications for Cognitive Improvement in Alzheimer's Disease
- (2018) Jun Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- EGCG ameliorates high-fat– and high-fructose–induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS
- (2017) Yashi Mi et al. FASEB JOURNAL
- Diabetes and Alzheimer’s Disease: Can Tea Phytochemicals Play a Role in Prevention?
- (2017) Warnakulasuriya M.A.D.B. Fernando et al. JOURNAL OF ALZHEIMERS DISEASE
- Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes
- (2017) Shan-Bo Ma et al. Molecular Medicine Reports
- New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9
- (2017) Elena Sánchez-López et al. Nanomedicine-Nanotechnology Biology and Medicine
- Stop Alzheimer’s before it starts
- (2017) Eric McDade et al. NATURE
- ER stress and the unfolded protein response in neurodegeneration
- (2017) Claudio Hetz et al. Nature Reviews Neurology
- (−)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer’s disease
- (2017) Yufang Guo et al. NEUROREPORT
- Obesity as a risk factor for Alzheimer's disease: weighing the evidence
- (2017) S. Alford et al. Obesity Reviews
- Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease
- (2017) Somang Kang et al. YONSEI MEDICAL JOURNAL
- On the path to 2025: understanding the Alzheimer’s disease continuum
- (2017) Paul S. Aisen et al. Alzheimers Research & Therapy
- Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
- (2017) Marcelo N. N. Vieira et al. Frontiers in Aging Neuroscience
- The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice
- (2017) Marco Cascella et al. Infectious Agents and Cancer
- Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
- (2017) Jin-Jing Jia et al. Frontiers in Pharmacology
- Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe / PS1dE9 through multiple signaling pathways
- (2017) Miren Ettcheto et al. Redox Biology
- Protective role of epigallocatechin-3-gallate in health and disease: A perspective
- (2016) Animesh Chowdhury et al. BIOMEDICINE & PHARMACOTHERAPY
- Long-Term Consumption of High-Fat Diet in Rats: Effects on Microglial and Astrocytic Morphology and Neuronal Nitric Oxide Synthase Expression
- (2016) Kinga Gzielo et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia
- (2016) James Cheng-Chung Wei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer’s Disease Stage in APP/PS1 Mice
- (2016) Miren Ettcheto et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
- (2016) Do-Geun Kim et al. Journal of Neuroinflammation
- Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2016) Rafael de la Torre et al. LANCET NEUROLOGY
- Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats
- (2016) Abhishek Kumar Singh et al. MOLECULAR NEUROBIOLOGY
- Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity
- (2016) Takuji Suzuki et al. MOLECULES
- Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer’s Disease
- (2015) Wioletta Rozpedek et al. CURRENT MEDICINAL CHEMISTRY
- (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression
- (2015) Xiang Chang et al. EXPERIMENTAL CELL RESEARCH
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization
- (2015) Dongjie Wang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
- (2015) Neha Atulkumar Singh et al. Nutrition Journal
- Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons
- (2015) Adrianne S. Chesser et al. NUTRITIONAL NEUROSCIENCE
- Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
- (2014) F. G. De Felice et al. DIABETES
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- ATF4: a Novel Potential Therapeutic Target for Alzheimer’s Disease
- (2014) Na Wei et al. MOLECULAR NEUROBIOLOGY
- Insulin resistance in Alzheimer's disease
- (2014) Kelly T. Dineley et al. NEUROBIOLOGY OF DISEASE
- Alzheimer’s as a metabolic disease
- (2013) Lloyd A. Demetrius et al. BIOGERONTOLOGY
- Alzheimer’s disease and insulin resistance: translating basic science into clinical applications
- (2013) Fernanda G. De Felice JOURNAL OF CLINICAL INVESTIGATION
- (−)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus
- (2013) Ning Jia et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- (−)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice
- (2013) Mingyan Liu et al. MOLECULAR NEUROBIOLOGY
- Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people
- (2013) F. A. Sorond et al. NEUROLOGY
- Glucose Levels and Risk of Dementia
- (2013) Paul K. Crane et al. NEW ENGLAND JOURNAL OF MEDICINE
- The case for soluble Aβ oligomers as a drug target in Alzheimer's disease
- (2013) Franz Hefti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance Through Cocoa Flavanol Consumption in Elderly Subjects With Mild Cognitive Impairment
- (2012) Giovambattista Desideri et al. HYPERTENSION
- Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties
- (2012) Young-Jung Lee et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice
- (2012) Henrik Ortsäter et al. Nutrition & Metabolism
- The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor
- (2011) Xiao-Rui Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
- (2011) Ying Liu et al. JOURNAL OF PATHOLOGY
- Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders
- (2011) Giovanni Scapagnini et al. MOLECULAR NEUROBIOLOGY
- Structure and permeability changes of the blood-brain barrier in APP/PS1 mice: an Alzheimer’s disease animal model
- (2011) Yulin Wang et al. Neurochemical Journal
- CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease
- (2010) A. Caccamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ADAM10 as a Therapeutic Target for Cancer and Inflammation
- (2009) Howard Crawford et al. CURRENT PHARMACEUTICAL DESIGN
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now